A broad molecular framework of how neural stem cells are specified toward astrocyte fate during brain development has proven elusive. Here we perform comprehensive and integrated transcriptomic and epigenomic analyses to delineate gene regulatory programs that drive the developmental trajectory from mouse embryonic stem cells to astrocytes. We report molecularly distinct phases of astrogliogenesis that exhibit stage-and lineage-specific transcriptomic and epigenetic signatures with unique primed and active chromatin regions, thereby revealing regulatory elements and transcriptional programs underlying astrocyte generation and maturation. By searching for transcription factors that function at these elements, we identified NFIA and ATF3 as drivers of astrocyte differentiation from neural precursor cells while RUNX2 promotes astrocyte maturation. These transcription factors facilitate stage-specific gene expression programs by switching the chromatin state of their target regulatory elements from primed to active. Altogether, these findings provide integrated insights into the genetic and epigenetic mechanisms steering the trajectory of astrogliogenesis.
In Brief
Neural stem cells give rise to both neurons and glia. Modeling gliogenesis in vitro, Tiwari et al. show that the generation of astrocytes involves several transcriptionally and epigenetically distinct stages. The authors found that the transcription factors NFIA, ATF3, and RUNX2 play pivotal roles in establishing these stages.
INTRODUCTION
A comprehensive understanding of the molecular mechanisms underlying cellular diversity and cell-fate specification during CNS development remains elusive. In the developing CNS, neural precursor cells (NPCs) are known to give rise first to neurons and then to glia such as astrocytes and oligodendrocytes (Kriegstein and Alvarez-Buylla, 2009 ). The molecular circuitry underlying the differentiation of NPCs into astrocytes is only beginning to be untangled. Astrocytes are involved in various functions that are important for the establishment, maintenance, and plasticity of the brain (Tiwari and Berninger, 2017) . Because of these important roles, malfunctions in astrocytes have been implicated in many neurological diseases (Molofsky et al., 2012) .
Despite these advances, the gene regulatory mechanisms that control the differentiation and maturation of astrocytes from NPCs, hereafter referred to as astrogliogenesis, remain to be uncovered. A plethora of signaling pathways are known to play a critical role in the differentiation of NPCs into astrocytes (Kanski et al., 2014) . For instance, BMP2 promotes STAT3-mediated astrogliogenesis by forming a STAT3-SMAD1-p300 co-activating complex that initiates expression of astrocyte-specific genes by binding to their promoters (Fukuda et al., 2007; Nakashima et al., 1999) . In addition to STAT3 (Bonni et al., 1997; Moon et al., 2002) , several other transcription factors (TFs), including SOX9, NFIA (Kang et al., 2012) , ETV5/ERM (Li et al., 2012) , and ZBTB20 (Nagao et al., 2016) , have been implicated as important in astrogliogenesis. Emerging evidence implies that these TFs interplay with epigenetic mechanisms to regulate astrocytespecific genes. At the onset of astrogliogenesis, STAT3 binds to the Gfap promoter and promotes DNA demethylation, resulting in gfap expression (Fan et al., 2005) . Similarly, NOTCH signaling induces the expression of Nfia in neural progenitor cells, which then targets the promoters of astrocyte-specific genes and causes DNA demethylation at these promoters by displacing DNMT1 (Namihira et al., 2009) . Furthermore, at the onset of gliogenesis, the Polycomb group (PcG) proteins repress pro-neuronal genes, such as Neurog1, thereby restricting the neurogenic competence of NPCs (Hirabayashi et al., 2009) . Finally, proteins of the high-mobility group nucleosome-binding family, HMGN1, HMGN2, and HMGN3, also play a critical role in promoting differentiation of astrocytes (Nagao et al., 2014) . Despite these exciting advances, a comprehensive understanding of the transcriptional and epigenetic mechanisms acting along the differentiation trajectory from NPCs to astrocytes remains elusive. In addition, although the enhancers have a known role in cell-fate specification (Buecker et al., 2014) , no studies have performed an in-depth investigation to identify the regulatory elements that are involved in defining the distinct phases of astrogliogenesis and the epigenetic mechanisms and TFs that operate at these sites during this process.
Here we used a model of astrogliogenesis from mouse embryonic stem cells in combination with next-generation sequencing and computational approaches to pinpoint distinct stages along the differentiation trajectory by identifying stage-specific transcriptional programs and epigenetic states. This quest allowed us to discern stage-and lineage-specific regulatory elements that represent putative targets of the TFs Nfia, Atf3, and Runx2.
RESULTS

Distinct Gene Expression and Epigenetic Landscape Define Stages of Astrogliogenesis
To investigate the gene regulatory mechanism underlying astrogliogenesis, we first adapted an experimental model that uses mouse embryonic stem cells (ESCs) to generate highly enriched astrogliogenic neural precursor cells (aNPCs) that subsequently differentiate into astrocytes (early astrocyte [eA] and mature or late astrocyte [lA] ) ( Figure 1A ; Figure S1A ) (Conti et al., 2005; Pollard et al., 2006) . qRT-PCR and immunoblot analyses showed that these astrocytes express established markers (e.g., Gfap, S100b, Nfia, Glast, Aqp4, and Cx43) (Figures S1B and S1C; Figure 1A) . Using markers for neuronal cells (TUBB3 and DCX) and progenitor cells (NES, OLIG2, and ASCL1), we found that these cultures exhibit a minimal presence of these cells ( Figure S1D ). However, we observed differences in the expression levels of AQP4, GLAST, and CX43, indicative of astroglial heterogeneity ( Figure S1D ). The differentiation of aNPCs into astrocytes was accompanied by a cessation of cell proliferation ( Figure S1E ). Furthermore, we found that similar to astrocytes in vivo, mature astrocytes generated calcium signals upon mechanical stimulation that propagated to neighboring astrocytes, indicative of their functional maturation (Figures S1F and S1G) . In line with previous studies, aNPCs were able to generate neurons when leukemia inhibitory factor (LIF) and fetal bovine serum (FBS) were withdrawn from the differentiation medium ( Figure S1H ) (Conti et al., 2005; Pollard et al., 2006) .
To measure the global gene expression changes that accompany astrogliogenesis, we performed high-coverage transcriptome profiling (RNA sequencing [RNA-seq]) of ESCs, aNPCs, and astrocytes at various stages of differentiation, spanning the early and later phases (1, 5, and 21 days, hereafter referred as eA, lA_1, and lA_2, respectively). A principal-component analysis (PCA) of the transcriptome datasets uncovered a progressive separation of the transcription profiles during astrogliogenesis, suggesting that the acquisition of distinct gene expression programs gave rise to stage-specific cellular identity ( Figure 1B) . The differential expression analysis of the contiguous stages of astrogliogenesis revealed major differences among the early stages, while the stages lA_1 and lA_2 were transcriptionally similar, indicating that terminal astroglial gene expression was largely established at lA_1 ( Figure 1B) . Thus, in the subsequent analysis, we focused on the mature or late astrocytes, hereafter referred to as lA. We then identified genes that were differentially expressed using pairwise comparisons of subsequent stages during astrogliogenesis ( Figure S1I ; Table  S1 ) and grouped them into five clusters ( Figure 1C ; Table S2 ), in temporal order, according to their expression kinetics during astroglial differentiation. Moreover, genes that were highly expressed during astrogliogenesis from mouse ESCs were highly expressed in astrocytes in vivo (Cahoy et al., 2008; Zhang et al., 2016) and at higher levels than those found in neurons (Figure 1C) . This analysis showed progressive changes in the expression profiles and reflected the developmental trajectory as supported by gene ontology (GO) term analysis of these gene clusters, showing enrichment of stage-relevant biological pathways (Table S2 ). Cluster 1 (ESC genes) and cluster 2 (ESC/aNPC genes) were enriched with genes involved in cellcycle and metabolic pathways, reflecting the proliferative activity of these cell types and the associated high metabolic rate (Table  S2 ; Figure 1C ; Figures S1J and S1K). Cluster 3 (aNPC/eA) and cluster 4 (eA) showed enrichment with genes involved in nervous system development, reflecting the ongoing process of astrogliogenesis (Table S2 ; Figure 1C ; Figures S1L and S1M). Cluster 5 (lA_1 and lA_2) was enriched with GO terms such as signaling and cytokine response, which are features that have been linked to mature astrocytes (Michelucci et al., 2016) (Table  S2 ; Figure 1C ; Figure S1N ). Consistent with the progressive differentiation and maturation of astrocytes, we found that Gfap was induced at the onset of astroglial differentiation (eA), while the maturation marker Aqp4 only appeared during later stages ( Figure 1D ). In contrast, the mature neuronal marker Rbfox3 was never expressed during astrogliogenesis ( Figure 1D ). In addition, a comparison of our datasets with the astrocyte gene expression data retrieved from Network Glia (http://www. networkglia.eu), which includes published datasets (Cahoy et al., 2008) , revealed similar expression kinetics in signature genes of in vivo-and in vitro-differentiated astrocytes (Figure S1O) . Altogether, these features confirm that our in vitro astrogliogenesis model is highly suitable for studying gene regulatory mechanisms underlying astrocyte differentiation. Furthermore, our observations clearly highlight that the consecutive stages of astrogliogenesis can be defined by distinct gene expression profiles.
Acetylation of lysine 27 at histone H3 (H3K27ac) marks active proximal and distal regulatory elements (Creyghton et al., 2010; Shlyueva et al., 2014) . To identify these regulatory regions, we generated H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) profiles during the stages of astrogliogenesis (aNPC, eA, and lA) ( Figure S1P ). Single-gene visualizations showed an expected enrichment in H3K27ac levels at astroglial genes (e.g., Gfap and Aqp4), while neuronal genes (e.g., Rbfox3) failed to show enrichment of this mark during astrogliogenesis (Figure 1E) . Although the total number of H3K27ac-enriched sites Immunofluorescence staining of DAPI and GFAP in the ESC-derived astrocytes during phases of astrogliogenesis, including aNPC, eA, lA_1, and lA_2. Scale bar is 100 mm.
(B) Principal-component analysis plot depicting the distribution of the transcriptomes of ESC (pink), aNPC (light blue), eA (dark blue), and two stages of lA (shades of green) within the scope of the first two components after RNA-seq in these stages. The x and y axes show the percentage of variance explained by the first 2 principal components. (C) Left side: clustered heatmap depicting the expression of differentially expressed genes during any stage of the in vitro astroglial differentiation, along with the names of known key genes in each of these clusters. Expression in the heatmap is scaled from blue (lowest) to red (highest). Right side: locally weighted scatterplot smoothing (lowess) regression line for these clusters in the same order as the published astrocyte transcriptomes by Cahoy et al. (2008) and Zhang et al. (2016 Figures S1Q and S1R ). The genomic distribution of H3K27ac-enriched sites revealed its very similar occurrence at promoters and non-promoter (or 'distal', including intergenic, exons, and introns) regions in aNPC, eA, and lA stages ( Figure 1F ). However, the stage-specific H3K27ac sites were predominantly located in non-promoter regions, except for eA ( Figure 1F ). We also validated that the H3K27ac enrichment at promoter and distal regions of several known astrocyte genes increased during astroglial differentiation using ChIP-qPCR experiments (Figures S1S and S1T). To identify genes putatively regulated by the distal H3K27ac sites, we assigned genes according to proximity (À50 kb) to the stagespecific distal H3K27ac sites. Although many of these sites shared the same nearest gene, many genes were uniquely associated with stage-specific H3K27ac-enriched sites ( Figure 1G ). These non-overlapping genes were expressed at significantly higher levels at their corresponding stages, except for the eA stage ( Figure 1H ).
Epigenetic Priming Precedes Stage-Specific Acquisition of Active Chromatin at Regulatory Regions during Astrogliogenesis
Mono-methylation of lysine 4 at histone H3 (H3K4me1) marks primed or active enhancers in the absence or presence of H3K27ac, respectively (Creyghton et al., 2010) . Given the critical role of the crosstalk among various chromatin marks at regulatory elements in defining cell-type-specific gene expression programs, we investigated whether H3K27ac enrichment is related to the occurrence of H3K4me1 at these sites during astrogliogenesis. Toward this end, we generated H3K4me1 ChIP-seq profiles during the stages of astrogliogenesis (aNPC, eA, and lA) ( Figure S2A ). Further analysis revealed a substantial number of stage-specific H3K4me1-enriched regions, which were nearly three-fold higher in lA ( Figure S2B ). The genes with H3K4me1-enriched promoters included Gfap and Aqp4, which already exhibited high levels of H3K4me1 in aNPC before acquisition of H3K27ac ( Figure 1E ) and transcription (Figures 2A and 2B) at the eA and lA stages, respectively, indicative of priming. High levels of H3K4me1 were also detected at the promoters of neurogenic genes, such as Rbfox3 in aNPC ( Figure 2C ). These H3K4me1-enriched regions were not only at the promoters of astrocyte-specific genes but also at the distal regions, as validated by ChIP-qPCR assays ( Figures S2C and S2D ). Astrocyte-specific genes were either not primed or minimally primed in ESCs, and they acquired priming only upon commitment to the astrocyte lineage, i.e., in astrocyte progenitor cells (aNPCs) (Figures S2C and S2D) .
We next investigated the H3K4me1 enrichment patterns at the stage-specific H3K27ac sites during astrogliogenesis. A profile plot depiction of these H3K27ac sites revealed their stage-specific high enrichment during astrogliogenesis ( Figures 2D-2F ). The aNPC-specific H3K27ac sites showed the highest enrichment of H3K4me1 at the aNPC state, and upon astrocyte differentiation, H3K27ac enrichment was lost in these regions and H3K4me1 levels were reduced ( Figures 2D and 2G ). eA-specific H3K27ac sites were already marked by H3K4me1 in aNPC, and H3K4me1 enrichment patterns were maintained through the eA stage while gaining H3K27ac (Figures 2E and 2H) . Furthermore, these regions lost H3K27ac at the lA stage, and the levels of H3K4me1 were reduced. Similarly, lA-specific H3K27ac sites gained H3K4me1 at the eA stage and increased this mark at the lA stage ( Figures 2F and 2I ). These data suggest that epigenetic priming of astroglial genes occurs before their acquisition of an active chromatin state and transcriptional activation.
We then attempted to unravel the distinct set of genes that show different dynamics of H3K27ac at the H3K4me1 primed sites during astrogliogenesis versus neurogenesis and extended these analyses to reveal the gene regulatory landscapes that contribute to the divergence of these two lineages. Therefore, we adapted an established system in which ESCs differentiate into neurogenic neural precursor cells (nNPCs) and subsequently into terminally differentiated neurons (TNs) via different stages (early neuron [eN] and late neuron [lN]) (Bibel et al., 2004 ) ( Figure S2E ). Previous studies have shown distinct epigenomic and transcriptomic changes in this model of neurogenesis that closely mimicked in vivo (Mohn et al., 2008; Stadler et al., 2011; Thakurela et al., 2015) . A clustering analysis of the regions primed in aNPC produced seven sets of patterns ( Figure 2J Table S3 ). Clusters 1, 3, and 5 showed minimal dynamics of H3K4me1 and H3K27ac during both astrogliogenesis and neurogenesis. Cluster 2 represented regions primed in aNPC that gain H3K27ac only during neurogenesis. Further analysis of cluster 2 showed that this cluster contains genes that are specific to neuronal differentiation, such as NeuroD1, Neurog1, and Neurog2 ( Figure 2K ), supporting multipotency at the aNPC stage. Cluster 4 contained genes that are marked by H3K4me1 without subsequent enrichment of H3K27ac in either lineage. Finally, clusters 6 and 7 contained sites that are primed in aNPC and gain H3K27ac specifically during astrogliogenesis. These clusters comprise astrocyte-specific genes, such as Gfap, Aqp4, Aldh1l1, Aldoc, Cd44, and S100b ( Figure 2L ). The switch from a primed to an active state is accompanied by a transcriptional induction of genes in the nearest to these sites (Figure S2G) . GO analysis of cluster 2 showed enrichment of genes related to neuronal differentiation ( Figure S2H ), whereas cluster 6-and cluster 7-specific genes were related to cell signaling and cell morphogenesis ( Figure S2I ). Furthermore, cluster 6-and cluster 7-contained sites were primed in nNPC, eN, and lN, whereas they never gained H3K27ac during neuronal differentiation ( Figures 2M and 2N ). Altogether, these data reveal epigenetic priming in regulatory elements, which precedes the stage-specific acquisition of active chromatin and transcriptional activation during astrogliogenesis.
Distinct TFs Shape the Epigenetic Landscape to Demarcate Astrocyte versus Neuronal Fate
Prompted by our finding that these regulatory elements are dynamically used during astrogliogenesis, we were interested in identifying TFs that function at these elements and how they differ from the factors that orchestrate neurogenesis. Using datasets from the neuronal differentiation model described earlier (Bibel et al., 2004; Thakurela et al., 2015) , our analysis revealed strikingly different gene expression programs during astrocytic differentiation compared to neuronal differentiation ( Figure S3A ) and a large number of genes differentially expressed for aNPC versus nNPC, eA versus eN, and lA versus lN ( Figures S3B-S3D ). GO analysis revealed that highly induced genes in aNPC were enriched for nervous system development, including gliogenesis (aNPC versus nNPC) ( Figure S3E ). Furthermore, the genes highly upregulated in eAs compared to eNs were enriched for proliferation-, migration-, and cell adhesion-related genes ( Figure S3F ). Finally, the genes that were more higher expressed in lAs versus lNs were enriched with functions such as signaling and cytokines ( Figure S3G ). In addition to the TFs and epigenetic regulators (ERs) known to be relevant for astrogliogenesis, such as Nfia (Deneen et al., 2006; Piper et al., 2010) , this list contained several TFs and ERs whose function in astrogliogenesis is unknown (Figures S3H-S3M; Table S1 ).
To reveal the differential chromatin landscape during astroglial versus neuronal differentiation, we compared the uniquely enriched H3K27ac sites during various stages of astrogliogenesis to those of the corresponding stages of neurogenesis ( Figure  3A ; Figure S3N ). This comparison revealed that stage-specific H3K27ac-enriched regions were largely unique to this lineage and did not occur during neurogenesis ( Figure S3N ). Similar findings were observed in comparisons with tissues from other lineages ( Figures S3O and S3P ). We then investigated whether H3K27ac-enriched genomic regions during astrogliogenesis recruit TFs that are similar to or different from those that are recruited during neurogenesis. Thus, we performed a motif enrichment analysis of the unique H3K27ac peaks during each stage of astrogliogenesis, compared these peaks with those that occurred during the corresponding stages of neurogenesis, and extended similar analysis to common peaks ( Figure 3A) . Although several enriched TF motifs were common between the astrogliogenesis and the neurogenesis stages, a remarkable number of motifs were unique to the astrocyte or the neuronal differentiation stages (Figures 3B-3D ; Figure S3Q ; Table S4 ). These motifs included binding sites for many TFs that have previously been shown to be critical for astrogliogenesis (e.g., Nfia and Runx2) and neurogenesis (e.g., Lhx2 and Brn1) (Table S4) (Deneen et al., 2006; Dominguez et al., 2013; Okawa et al., 2016; Subramanian et al., 2011) . This analysis revealed several additional TFs that have not been previously implicated in astrogliogenesis and neurogenesis, thus warranting further investigation. TFs that function at distal regulatory elements often contribute to the activation of these sites (Shlyueva et al., 2014; Thakurela et al., 2015) . Therefore, we investigated whether the TFs that were predicted to be enriched at the active regulatory elements during astrogliogenesis contribute to the active chromatin state in these regions ( Figure 3A ; Figure S3Q ). Thus, we performed small interfering RNA (siRNA)-mediated depletion of selected stage-specific TFs during the eA and lA stages and shortlisted the TFs whose knockdown impaired the acquisition of astrocyte markers ( Figure 3A ; Figures S3R-S3T ). This approach led to the identification of Nfia and Atf3 at the eA stage and Stat3, Runx2, and Prdm9 at the lA stage of astrogliogenesis ( Figure 3A ; Figures  S3R-S3U ). While Nfia was expressed during each stage of astroglial differentiation, Atf3 and Stat3 are specifically upregulated in eA and lA, respectively ( Figures S3V and S3W ). In contrast, Runx2 (Figures S3V and S3X) and Prdm9 showed highest expression in lA and aNPC, respectively ( Figure S3V ). However, while Nfia, Atf3, and Stat3 transcription was low during neurogenesis, Prdm9 and Runx2 showed higher expression (Figure S3V) . We then investigated whether knockdown-induced defects in the astrocytic gene expression were due to an aberrant epigenetic state at the target distal regulatory elements. Therefore, we assessed the levels of H3K27ac at putative target sites using ChIP-seq analysis after their depletion during astrogliogenesis. The loss of Nfia and Atf3 in eA and the loss of Runx2 in lA led to a reduction in the H3K27ac levels at putative distal target sites, while the depletion of the other TFs (Stat3 and Prdm9) did not have such an effect ( Figures 3E-3I ). These global observations were validated by single-locus visualizations ( Figures 3J-3L ). In summary, these findings reveal lineage-specific TFs that shape the epigenetic landscape of distal regulatory elements during astrocyte differentiation and maturation.
Stage-and Lineage-Specific Activation of Regulatory Elements during Astrogliogenesis and Neurogenesis
Prompted by our findings that distinct TFs are required for conferring an active chromatin state to distal regulatory elements, we next investigated the activation dynamics of the TFtarget elements during astrogliogenesis and neurogenesis by measuring H3K27ac levels specifically at these sites. Putative Nfia and Atf3 sites were highly enriched with H3K27ac only during the eA stage of astrogliogenesis; these sites remained devoid of H3K27ac during neurogenesis (Figures 4A and 4B ; Figures  S4A-S4F ). Conversely, a similar analysis of the eN-specific TF Lhx2 showed that its putative target sites gain H3K27ac in eN, but not in eA ( Figure 4C ; Figures S4G-S4I ). The expression of the genes nearest to these sites also tended to be higher in eA compared to that in eN for both Nfia and Atf3, while in the case of Lhx2, the nearest genes were induced in eN, but not in eA (Figures 4D-4I) . Similarly, putative Runx2 and Brn1 sites showed elevated H3K27ac only in lA and lN, respectively (Figures 4J  and 4K ; Figures S4J-S4O ). In keeping with this, the genes nearest to these Runx2 and Brn1 sites were significantly induced in IA and lN, respectively ( Figures 4L-4O ). In addition, by comparing the sites putatively occupied by Nfia, Atf3, and Runx2 at all H3K27ac peaks throughout astrogliogenesis, we observed eA stage-specific H3K27ac enrichment at Nfia and Atf3 motifs and lA stage-specific H3K27ac enrichment at the Runx2 motif ( Figure S4P ). Consistent with our previous observations, Nfia, Atf3, and Runx2 sites were already primed during the preceding stage, before they acquired H3K27ac in eA and lA, respectively ( Figures 4A, 4B, and 4J) . Altogether, our data suggest that Nfia, Atf3, and Runx2 are crucial for switching the chromatin state of their putative target elements from primed to active, thereby driving the gene expression program underlying astrocyte differentiation and maturation.
Nfia, Atf3, and Runx2 Mediate Gene Expression Programs Underlying Astrogliogenesis To further investigate the target genes that are under the direct transcriptional control of Nfia, Atf3, and Runx2, we performed transcriptome profiling (RNA-seq) after performing an siRNAmediated depletion of these TFs at the eA stage (Nfia and Atf3) or the lA stage (Runx2). Our analysis revealed a large number of differentially expressed genes after their depletion (Figures 5A-5C; Table S1 ). Depletion of Nfia and Atf3 led to changes in astrocyte morphology, as well as downregulation in astroglial markers, such as Gfap, Aldh1l1, Aldoc, and Aqp4, while Runx2 knockdown resulted in the downregulation of genes such as Nfia, Cx43, and Aqp4, but not of other markers, such as Gfap, which was even upregulated, suggesting a potential role for Runx2 in preventing a reactive state ( Figure 5D ; Figures S5A  and S5B ). While Nfia depletion had no effect on proliferation, apoptosis, or cell cycle ( Figures S5C-S5E ), Atf3 and Runx2 knockdown reduced apoptosis ( Figures S5C-S5E ) and Runx2-depleted cells exhibited G0/G1 arrest ( Figures S5C-S5E) .
The genes that were downregulated or upregulated after the Nfia depletion exhibited enrichment in extracellular matrix organization-and neuronal differentiation-related GO, respectively, suggesting that Nfia may repress the neurogenesis-related program ( Figure 5E ). However, genes that were downregulated or upregulated after the Atf3 knockdown were enriched with terms related to cell adhesion or mitotic cell-cycle processes, respectively, implying that these genes are relevant for exiting the cell cycle and entering astrocyte differentiation ( Figure 5F ). In contrast, after Runx2 depletion, the downregulated genes were enriched with GO terms related to cell morphogenesis and differentiation, while the upregulated genes were enriched with genes related to cytokine response, suggesting that Runx2 promotes differentiation and may counteract acquisition of a reactive phenotype ( Figure 5G ). Single-gene examples substantiated our observations that Nfia and Atf3 promote astrogliogenesis by suppressing neurogenesis and promoting cell-cycle exit of progenitors, respectively, while Runx2 counteracts activation of a reactive phenotype to promote astrocyte maturation (Figures 5H-5J) . Genes that were downregulated upon Nfia, Atf3, and Runx2 depletion were upregulated during astrogliogenesis, corroborating the specific role of these TFs in astrogliogenesis ( Figures S5F-S5H ). In addition, the genes downregulated upon Nfia and Atf3 knockdown are expressed at a higher level in astrocytes compared to neurons, and an opposite pattern was observed for the upregulated genes ( Figures S5I and S5J) . We did not observe differential expression in astrocytes versus neurons in the case of Runx2-deregulated genes ( Figure S5K ).
To determine whether the regulatory landscape of the deregulated genes is also altered following TF depletion, we assessed H3K27ac enrichment at stage-specific regulatory sites nearest to these genes (Atf3 and Nfia for eA and Runx2 for lA). In each case, downregulated genes lost H3K27ac enrichment upon knockdown of these factors, indicating that these TFs have an activating function at these sites ( Figures 5K-5M ). Strikingly, in the case of upregulated genes, H3K27ac enrichment at their regulatory sites did not change for Atf3 and Runx2 and only slightly increased for Nfia, suggesting that the activation of these genes was likely a result of secondary cascades. Overall, our data suggest that Nfia, Atf3, and Runx2 are critical for mediating the gene expression programs underlying astrogliogenesis. Nfia, Atf3, and Runx2 Directly Bind Predicted Target Elements and Induce Chromatin Accessibility Given the known cooperativity among TFs that control cell-fate decisions, we assessed whether Nfia and Atf3 collaborate to regulate early astrogliogenesis. A comparison of the transcriptome data after Nfia and Atf3 knockdown revealed a significant overlap among the genes that were downregulated after their depletion (n = 198 genes), suggesting similar aberrations in the astrogliogenesis program after their knockdown ( Figure S6A ; Table S5 ). Based on H3K27ac enrichment, a significant set of genes that were commonly downregulated after Nfia and Atf3 depletion exhibited binding sites for both TFs (n = 47/198), suggesting their potential direct cooperativity during astrocyte differentiation ( Figure 6A ; Figure S6A ). Given our findings that Nfia, Atf3, and Runx2 are crucial for switching the chromatin state of distal regulatory elements from primed to active, we next investigated whether these factors bind the predicted target elements at the respective stages of astrogliogenesis. Toward this end, we reanalyzed our datasets to validate the reduction in expression and H3K27ac enrichment at selected target genomic loci following depletion of these TFs ( Figures S6B-S6I ) Next, ChIP assays for Nfia and Atf3 in eA and Runx2 in lA to demonstrated binding at the selected target sites (Figures 6B-6E ).
Finally, we investigated whether the target sites of these TFs gain in accessibility while they are bound by these TFs and whether this increase in accessibility depends on the presence of these factors. Assay for transposase-accessible chromatin (ATAC) showed that these sites become more open in the corresponding stages concomitant to TF binding and acquisition of H3K27ac (Figures 6F-6I; Figures S6J-S6M) . Conversely, following depletion of these TFs, these target sites showed a significant reduction in chromatin accessibility (Figures 6F-6I; Figures S6N-S6Q ). Together with our previous observations, these data support the notion that Nfia, Atf3, and Runx2 directly target distal regulatory elements and induce their active state, as manifested by increased chromatin accessibility, to drive gene expression programs underlying the differentiation and maturation of astrocytes. (legend continued on next page) exhibited high levels of H3K27ac at the identified TF-target regulatory elements ( Figures 7B-7E ). Further analysis using ChIP assays for Nfia, Atf3, and Runx2 confirmed the occupancy by these TFs at their predicted sites ( Figures 7F-7I ).
Given that these TFs were found to function in activation of astroglial-specific regulatory elements but were not engaged in activation of similar elements in neurogenesis, we hypothesized that the expression of these factors might interfere with the execution of neurogenesis programs during embryonic development. We thus performed in utero electroporation (IUE) of mouse cortical progenitors on embryonic day (E) 15.5 (Figueres-Oñ ate et al., 2016; Pataskar et al., 2016) with plasmids encoding NFIA, ATF3, or RUNX2 or a mixture of these three TFs (MIX) (Figures S7A and S7B) . The successful expression of the TFs was confirmed in HEK293T cells by immunoblotting ( Figure S7C ). At E18.5, cells electroporated with the control plasmid exhibited a typical distribution in the developing cortex that is characterized by migration to the cortical plate (CP) (54.8% ± 5.8% of red fluorescent protein (RFP)-positive cells in the CP, n = 3 animals) ( Figures 7J and 7K ). In contrast, most cells overexpressing each of the astrogliogenic TFs or their mixture failed to populate the CP (Figures 7J and 7K) . Instead, these cells were retained in the GLAST-positive progenitor zone (Figures 7J and 7K; Figure S7D ; Table S6 ). Furthermore, to evaluate whether the cells ectopically expressing these TFs are prevented from acquiring a neurogenic fate, we analyzed the expression of SATB2, a marker of upper-layer neurons generated at this embryonic stage, in electroporated cells ( Figure 7L ; Figure S7E ; Table S6 ). This analysis demonstrated that cells expressing any of these TFs alone or in combination fail to gain expression of SATB2, in line with their retention below the CP. Further analysis of the expression of the astroglial progenitor marker SOX9 in electroporated cells showed that the expression of these TFs causes neurogenic radial glia to generate a larger proportion of SOX9-positive progenitors ( Figure 7L ; Table S6 ).
To characterize the influence of the TFs at a later stage of development, we performed in utero electroporation in E15.5 cortical progenitors using MIX and analyzed at the P5 stage. Consistent with our results at E18.5, TF-overexpressing cells were mostly retained in the progenitor zone at P5, although most control-electroporated cells generated neuronal cells that already populated the upper cortical layers ( Figure 7M) . Moreover, we observed a significant increase in the number of SOX9-positive cells among TF-electroporated cells compared to control (Figures 7M and 7N ; Table S6 ). In contrast, a converse pattern was observed for the mature neuronal marker NeuN (Figures 7M and 7N ; Table S6 ). Altogether, these results suggest an increase in the generation of astroglial progenitors at the expense of neurons.
DISCUSSION
We aimed to identify key regulators of astrogliogenesis based on lineage-and stage-specific remodeling of the transcriptional and epigenetic landscapes during astrocyte differentiation. Using mouse ESC differentiation into astrocytes as a model system, we identified three transcriptionally and epigenetically distinct stages: (1) a progenitor stage (aNPC), (2) an early stage of astroglial differentiation (eA), and (3) a more advanced stage of astroglial differentiation (lA). We obtained evidence for epigenetic priming along the differentiation axis, indicating that astrogliogenesis follows a dynamic trajectory during which subsequent stages are being orchestrated by preceding ones. By searching for lineage-and stage-specific regulatory elements unique to each stage and inferring their most highly associated TF binding motifs, we were able to pinpoint drivers of the underlying differentiation trajectory: the TFs Nfia, Atf3, and Runx2. These TFs were found to be not only important for expression and maintenance of astroglial marker genes but also critically required for the epigenetic remodeling at the transition between distinct stages. Our molecular analysis of astrogliogenesis supports the notion that differentiation of neural precursors into astrocytes is not a one-step but rather a multi-phase process (Kang et al., 2012) . Furthermore, in vivo overexpression of these TFs together resulted in an increase in SOX9-positive progenitors at the expense of neurogenesis; however, because of the transient nature of the overexpression, a definitive cell fate could not be tracked. It is possible that the continuous expression of the TFs hampers proper astrocyte development and maturation, and using a system allowing temporally controlled TF expression could further drive the acquisition of an astrocytic phenotype.
A substantial body of prior work has provided compelling evidence for an important role of Nfia at the onset of astrogliogenesis, both in the developing spinal cord and in the cerebral cortex (Cebolla and Vallejo, 2006; Deneen et al., 2006; Kang et al., 2012) . However, the precise role of Nfia remains largely elusive. Combined expression of Nfia with Nfib and Sox9 can induce conversion of fibroblasts into astrocyte-like cells (Caiazzo et al., 2015) , supporting the notion of an instructive role in astrogliogenesis. The present study showed that Nfia is required for converting primed chromatin into a transcriptionally active one at the transition from aNPC to eA. Nfia also appears to play an important role in suppressing neuronal gene expression. Thus, Nfia may regulate distinct neuronal-fate-suppressing and astrocyte-fate-instructing gene expression modules. The latter module may be co-regulated by Atf3, because there was significant overlap of genes, comprising putative shared direct targets, that were downregulated following knockdown of either TF. Moreover, Nfia became downregulated following Atf3 knockdown, indicating that Atf3 may function upstream of Nfia. Like Nfia, Atf3 was found to be crucial for the conversion of primed to active chromatin. However, in contrast to Nfia, knockdown of Atf3 resulted in the upregulation cell-cyclerelated genes, supporting a specific role of Atf3 in cell-cycle exit at the progenitor stage. So far, Atf3 has been largely recognized as a stress response gene (Hai et al., 1999) . Stress response such as unfolded protein response (UPR) mediated by Atf4, itself known to induce Atf3, has been shown to regulate the stage-specific balance between direct and indirect neurogenesis from radial glia during cortical development (Laguesse et al., 2015) , thus setting a precedent for ATF-mediated cellfate decisions. Finally, a study identified Drosophila Atf3 as a cell polarity response gene. While there is ample evidence for an important role for cell polarity in the regulation of neuronal-fate decisions (Donohoe et al., 2018) , virtually nothing is known regarding the acquisition of a glial fate. Our study warrants further investigation into the functional importance of UPR and cell polarity regulation as potential mechanisms in astrogliogenesis.
Virtually nothing is known about Runx2 function in the CNS (Wang and Stifani, 2017) . Runx2 plays a key role in osteoblast and chondrocyte differentiation (Komori, 2018) . Computational modeling of stem cell-fate decisions predicted Runx2 as a determinant of astrogliogenesis, and Runx2 overexpression induced astroglial differentiation in mouse neural stem cells (Okawa et al., 2016) . One particularly intriguing observation was that knockdown of Runx2 resulted in the induction of genes associated with reactive astrocytes, suggesting that Runx2 may be important in repressing a reactive phenotype. Reactive astrogliosis represents in many respects a state of dedifferentiation and involves reacquisition of neural stem cell properties (Robel et al., 2011) , which can eventually reactivate neurogenic potential (Magnusson et al., 2014; Nato et al., 2015) . It will be interesting to learn whether such dedifferentiation involves downregulation of Runx2.
Consistent with its known function in astrogliogenesis (Bonni et al., 1997; Moon et al., 2002) , Stat3 was found to strongly influence astroglial marker expression following knockdown. Surprisingly, however, we failed to observe global changes in H3K27ac at its putative targets. Although we cannot exclude that Stat3 may induce chromatin remodeling via alternative mechanisms, such as sequence-independent recruitment of Stat3, our observation may genuinely indicate that Stat3 acts by transactivating already-accessible targets upon prior chromatin remodeling by pioneer TFs. Given its role in opening chromatin at the transition to the lA stage, Runx2 might be in a prime position to exert such a function. However, activation of Stat3 is also implicated in reactive astrogliosis (Herrmann et al., 2008) ; hence, Runx2 and Stat3 may act partially antagonistically to each other.
Although our study revealed compelling evidence for dynamic transcriptional and epigenetic remodeling during astrogliogenesis, it also raises intriguing questions regarding the molecular mechanisms that account for the epigenetic writing of specific priming marks at gene loci that subsequently become specifically activated in astrogliogenesis. Furthermore, how the TFs driving astrogliogenesis are activated during this process remains to be investigated. Lastly, we lack molecular insights into how the TFs mediate transition of the chromatin state of the target regulatory elements from primed to active. Deciphering these mechanisms will lead us to a better understanding of how glial and neuronal lineage diverge during development. Our study represents a rich resource for the identification and characterization of further regulators of such key decisions during CNS development.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for resource/reagents should be directed to and will be fulfilled by the Lead Contact, Prof. Dr. Benedikt Berninger (benedikt.berninger@kcl.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The handling of the mice and all experimental procedures were conducted in accordance with the European Union guidelines on the use and welfare of experimental animals (2010/63/EU). Experimental procedures were approved by the State of Rheinland Pfalz, Germany (23177-07/G17-1-067) or Spanish Ministry of Agriculture (RD 1201 (RD /2005 (RD and L 32/2007 ) and the Cajal Institute, CSIC Animal Experimentation Ethics Committees and the Community of Madrid (Ref. PROEX 223/16 ). Animals were housed on a 12:12 hr lightdark cycle, with free access to food and water. None of the mice used were involved in previous procedure or drug treatment. Both male and female embryos were used and randomly allocated to experimental groups.
Cell culture mESCs derived from C57/BL-6 mice were cultured in DMEM supplemented with 10% FBS, 2 mM Glutamax, 2 mM sodium pyruvate, 2 mM non-essential amino acids, Leukemia-inhibitory factor (LIF) and 50 mM b-mercaptoethanol. The cell medium was changed every day, and the cells were passaged every second day using 0.05% trypsin and plated on 0.2% gelatin coated plates. Using the protocol proposed by Conti et al., the ESCs were further differentiated into aNPC (Conti et al., 2005; Pollard et al., 2006) . Briefly, the ESCs were passaged and grown in N2/B27 media containing 0.5x DMEM-F12, 0.5x N2 supplement, 0.5x B27 supplement, 0.5x Neurobasal media, 2 mM Glutamax and 2 mM Penicillin-Streptomycin for 7 days on 0.2% gelatin coated plates. The cells were trypsinized and grown on uncoated dishes for the following 7 days in NSA media containing 10 ng/ml FGF2 and 10 ng/ml EGF to form cell aggregates. The formed aggregates were further passaged and grown on 0.2% Gelatin coated plated to obtain the monolayer of the aNPC. To generate the astrocytes, the aNPC were differentiated in differentiation media containing DMEM, 1% FBS, 1x B27, LIF, 2 mM Glutamax and 2 mM Penicillin-Streptomycin for 1, 5 and 21 days. For differentiation of aNPC into neurons, cells were kept in neurobasal media, along with B27 for 2 weeks. 293T cells were cultured in DMEM, 10% FBS, Penicillin-Streptomycin and Glutamax.
Primary astrocyte culture
The primary astrocyte culture was prepared from the brains of P5-P7 C57/BL6 mice using a previously described protocol (Heinrich et al., 2011) . Briefly, the cortices were dissected to remove the white matter and meninges and cultured in DMEM-F12 media supplemented with 1x B27, 10% FBS, 2 mM Glutamax and 2 mM Penicillin-Streptomycin.
